Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Versartis Inc (NASDAQ:VSAR)

2.60
Delayed Data
As of 3:59pm ET
 +0.05 / +1.96%
Today’s Change
2.35
Today|||52-Week Range
24.00
-82.55%
Year-to-Date

Today’s Trading

Previous close2.55
Today’s open2.60
Day’s range2.55 - 2.60
Volume738,831
Average volume (3 months)1,375,080
Market cap$90.9M
Dividend yield--
Data as of 3:59pm ET, 10/17/2017

Growth & Valuation

Earnings growth (last year)-9.51%
Earnings growth (this year)-27.91%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book0.59

Competitors

 Today’s
change
Today’s
% change
HSKAHeska Corp-0.62-0.64%
PRTKParatek Pharmaceutic...+0.50+2.11%
AMPHAmphastar Pharmaceut...-0.26-1.39%
RETAReata Pharmaceutical...+0.95+2.97%
Data as of 3:59pm ET, 10/17/2017

Financials

Next reporting dateNovember 9, 2017
EPS forecast (this quarter)-$1.01
Annual revenue (last year)$0.00
Annual profit (last year)-$95.8M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Jay P. Shepard
Chief Operating &
Financial Officer
Joshua T. Brumm
Corporate headquarters
Menlo Park, California

Forecasts